Biomarker test for Peripartum Cardiomyopathy could help reduce death after giving birth
Cardiologists have discovered biomarkers that can be used to develop a screening test to detect Peripartum Cardiomyopathy (PPCM), a life-threatening disorder that is the primary cause of mortality in pregnant women in developing countries. The results can lead to the immediate treatment of PPCM in new mothers and a significant reduction in mortality.<img src="http://feeds.feedburner.com/~r/sciencedaily/~4/51tzP9PzAO4" height="1" width="1"/>
